Cure My Disease

Don't miss your cure!

 Log in / Sign up

New RSV vaccine shows promise for seniors in large trial

NCT ID NCT06251024

Completed ⭐️ VACCINE ⭐️ Sponsor: Sanofi Pasteur, a Sanofi Company Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested an experimental RSV vaccine in about 4500 adults aged 60 and older. Half received the vaccine and half received a placebo shot. The goal was to see if the vaccine could prevent lower respiratory tract disease caused by RSV, a common virus that can be serious in older adults.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

respiratory syncytial virus infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY VOLUNTEERS RESPIRATORY SYNCYTIAL VIRUS INFECTION

Contacts and locations

Locations

  • Investigational Site Number : 0360001

    Southport, Queensland, 4222, Australia

  • Investigational Site Number : 0360002

    Camberwell, Victoria, 3124, Australia

  • Investigational Site Number : 0360003

    Botany, New South Wales, 2019, Australia

  • Investigational Site Number : 0360004

    Sippy Downs, Queensland, 4556, Australia

  • Investigational Site Number : 0360005

    Norwood, 5067, Australia

  • Investigational Site Number : 1520001

    Santiago, Reg Metropolitana de Santiago, 8380453, Chile

  • Investigational Site Number : 1520002

    Santiago, 7500657, Chile

  • Investigational Site Number : 1520004

    Santiago, Reg Metropolitana de Santiago, 8420383, Chile

  • Investigational Site Number : 1520005

    Santiago, Reg Metropolitana de Santiago, 7580206, Chile

  • Investigational Site Number : 1520006

    Concepción, Biobio, 4070094, Chile

  • Investigational Site Number : 1520008

    Santiago, 7510157, Chile

  • Investigational Site Number : 1700001

    Quindío, 630001, Colombia

  • Investigational Site Number : 1700002

    Barranquilla, 080020, Colombia

  • Investigational Site Number : 1700003

    Girardot, 252431, Colombia

  • Investigational Site Number : 1700004

    Aguazul, 856010, Colombia

  • Investigational Site Number : 1700005

    Ibague, 730001, Colombia

  • Investigational Site Number : 1700006

    Bogotá, 110111, Colombia

  • Investigational Site Number : 1700007

    Cali, 76001, Colombia

  • Investigational Site Number : 2140001

    Santo Domingo, 10205, Dominican Republic

  • Investigational Site Number : 2140002

    Santo Domingo, 10205, Dominican Republic

  • Investigational Site Number : 3400001

    San Pedro Sula, 21104, Honduras

  • Investigational Site Number : 3400002

    Tegucugalpa, 11101, Honduras

  • Investigational Site Number : 3400003

    Tegucigalpa, 11101, Honduras

  • Investigational Site Number : 4840002

    León, Guanajuato, 37000, Mexico

  • Investigational Site Number : 4840003

    Querétaro, 76100, Mexico

More trials for these conditions

Other studies related to the condition(s) this trial covers.